Dr Roebuck's
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Dr Roebuck's - overview
Established
2015
Location
Sydney, NSW, Australia
Primary Industry
Consumer Products
About
Dr Roebuck's is an Australian skincare company specializing in natural, cruelty-free products designed to promote healthy skin. The brand focuses on providing effective solutions that cater to various skin types and concerns. Dr Roebuck's was founded in 2015 in Sydney, Australia. The company is known for its dedication to creating effective skincare solutions, emphasizing natural ingredients.
The founder, who previously pursued ventures in the skincare industry, has cultivated a brand that resonates with health-conscious consumers. They completed a funding round in April 2019, when Dr Roebuck's raised an undisclosed amount from Unilever Ventures. Dr Roebuck's offers a range of skincare products that include moisturizers, serums, and treatments, all designed to enhance skin health. Their products are formulated with natural ingredients and cater to a diverse clientele, focusing on delivering quality solutions for various skin issues.
The brand is committed to cruelty-free practices and has gained recognition among customers in Australia and beyond, targeting individuals seeking effective skincare alternatives. The company generates revenue through direct sales of its skincare products, which are marketed via their e-commerce platform and select retail partnerships. Clients purchase these products at various price points, enabling Dr Roebuck's to scale its revenue in line with an increase in customer demand, particularly from those seeking high-quality, natural skincare solutions. In 2019, following their latest funding round, Dr Roebuck's plans to explore new product lines that incorporate innovative, natural ingredients aimed at expanding their offerings by the end of 2021.
The company is also looking to penetrate new markets, specifically targeting North America and Europe by 2022. The funding received will be utilized to support product development and marketing strategies to enhance brand visibility in these regions.
Current Investors
Unilever Ventures
Primary Industry
Consumer Products
Sub Industries
Beauty & Hygiene
Website
www.drroebucks.com
Verticals
E-commerce, Manufacturing
Company Stage
Early Stage
Total Amount Raised
Subscriber access only

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.